Black, Latino patients underrepresented in 'high-impact' cirrhosis clinical trials in US

WASHINGTON — Black and Latino patients are underrepresented in cirrhosis clinical trials, underpinning the need for systematic improvement, according to research presented at The Liver Meeting.“Almost 5 million adults in the United States live with chronic liver disease, and cirrhosis incidence is currently rising. We also know that there are racial and ethnic disparities in

Related Keywords

Washington ,United States ,Massachusetts ,Alaska ,American ,Alaskan ,Heather Biele ,Bykate Burba ,Nneka Ufere ,Hawaiian Pacific Islander ,Harvard Medical School ,Liver Meeting ,Massachusetts General Hospital ,American Indian ,Alaskan Native ,